Home > Insider Trading > Filing (0001140361-19-019740)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1720725	Oyster Point Pharma Inc.	OYST	()	4

Insiders

Cik	Name	Reported Address	Director	Officer	Large Shareholder	Other
1081714	R Henry Kravis	C/O Kohlberg Kravis Roberts &Amp; Co. L.p. 9 West 57Th Street, Suite 4200 New York NY 10019	No	No	No	No
1081715	R George Roberts	C/O Kohlberg Kravis Roberts &Amp; Co. L.p. 2800 Sand Hill Road, Suite 200 Menlo Park CA 94025	No	No	No	No
1404912	Kkr & Co. Inc.	C/O Kohlberg Kravis Roberts &Amp; Co. L.p. 9 West 57Th Street, Suite 4200 New York NY 10019	No	No	No	No
1472694	Kkr Management Llc	C/O Kohlberg Kravis Roberts &Amp; Co. L.p. 9 West 57Th Street, Suite 4200 New York NY 10019	No	No	No	No
1472697	Ltd Gp Holdings Fund Kkr	C/O Kohlberg Kravis Roberts &Amp; Co. L.p. 9 West 57Th Street, Suite 4200 New York NY 10019	No	No	No	No
1472698	L.p. Holdings Fund Kkr	C/O Kohlberg Kravis Roberts &Amp; Co. L.p. 9 West 57Th Street, Suite 4200 New York NY 10019	No	No	No	No
1743754	Kkr Group Holdings Corp.	C/O Kohlberg Kravis Roberts &Amp; Co. L.p. 9 West 57Th Street, Suite 4200 New York NY 10019	No	No	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock, Par Value $0.001 Per Share	Acquisiton	2019-11-04	884,622	$0.00	884,622	No	4	C	Indirect	See footnotes
Common Stock, Par Value $0.001 Per Share	Acquisiton	2019-11-04	155,000	$16.00	1,039,622	No	4	P	Indirect	See footnotes

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	C	Indirect	See footnotes
No	4	P	Indirect	See footnotes

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock, Par Value $0.001 Per Share	Series B Convertible Preferred Stock	Disposition	2019-11-04	884,622	$0.00	884,622	$0.00

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
0			No	4	C	Indirect

Footnotes

These shares of Series B Convertible Preferred Stock automatically converted into shares of the Issuer's Common Stock, on a one-for-one basis immediately prior to the completion of the Issuer's initial public offering.
The securities reported herein are held by Falcon Vision LLC. KKR Health Care Strategic Growth Fund L.P., as the managing member of Falcon Vision LLC, KKR Associates HCSG L.P., as the general partner of KKR Health Care Strategic Growth Fund L.P., KKR HCSG GP LLC, as the general partner of KKR Associates HCSG L.P., KKR Fund Holdings L.P., as the sole member of KKR HCSG GP LLC, KKR Fund Holdings GP Limited, as a general partner of KKR Fund Holdings L.P., KKR Group Holdings Corp., as a general partner of KKR Fund Holdings L.P. and the sole shareholder of KKR Fund Holdings GP Limited, KKR & Co. Inc., as the sole shareholder of KKR Group Holdings Corp., KKR Management LLC, as the Class B common stockholder of KKR & Co. Inc., and Messrs. Henry R. Kravis and George R. Roberts, as the designated members of KKR Management LLC, may be deemed to be the beneficial owners having shared voting and investment power with respect to the shares described in this footnote.
Each of Messrs. Kravis and Roberts disclaims beneficial ownership of the shares held by Falcon Vision LLC.